Abstract 301: Repurposing engineered thymoquinone nanoparticles to inhibit drug-resistant prostate cancer

Authors: Santosh Kumar Singh, Manoj Kumar Mishra, Rajesh Singh

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-301

Source: Full article

Abstract

Abstract